Pursuant to SEBI circular no. SEBI/HO/DDHS/CIR/P/2019/115 dated October 22 2019, Sun Pharmaceutical Industries has informed that Thursday, February 25, 2021 is the record date to determine the holders of Commercial Papers (CPs) of the Company whose names stand registered in the Register of Beneficial Owners maintained by Depositories in respect of the CPs held in electronic form under ISIN No. INE044A14625 and who are entitled to receive payment towards redemption amount on the Maturity Date February 26, 2021. The record date and further details are enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1862.70 |
| Dr. Reddys Labs. | 1356.85 |
| Cipla | 1465.15 |
| Zydus Lifesciences | 1112.20 |
| Lupin | 2420.15 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: